Takehiko Kaneko, Chief Medical Officer (CMO) of Heartseed Inc., will be speaking at the Global CVCT Forum, scheduled to take place from December 9 to 11, 2024 in Washington, D.C., USA.

What is the Global CVCT Forum?

The Global CVCT Forum (Cardiovascular Clinical Trialists Forum) is a prestigious international conference dedicated to advancing discussions on the forefront of clinical trials in cardiovascular diseases. Each year, the Forum brings together a diverse group of participants, including academic institutions, regulatory authorities (such as the FDA, PMDA and EMA), research institutions, editors of leading journals, patient organizations, industry representatives, and CROs (Contract Research Organizations).
With over 40 scientific sessions, the Forum provides an unparalleled platform for high-level discussions on the latest developments in clinical research and valuable networking opportunities.

Kaneko's Session

Session Title
CELL THERAPY TRIALS FOR HEART FAILURE: RIGHT CELLS? RIGHT TARGET POPULATION? RIGHT DESIGN?

In this session, distinguished researchers from the United States and Europe, as well as experts from the FDA, will discuss key topics, including:

• Comparisons between stem cell-derived products and iPS cell-derived products
• The potential of exosomes and secretomes
• Appropriate endpoints for clinical trials

etc.

Kaneko will deliver a presentation under the topic "Industry viewpoint", sharing insights on Heartseed's initiatives and strategies for clinical trials.

Access the Latest Program

The latest version of the Global CVCT Forum's scientific program is available for download on the official website. Please find the details here:
Global CVCT Forum Scientific Program 

For Media Inquiries

For additional information about Heartseed's initiatives or the details of this Forum, or to arrange an interview with Takehiko Kaneko, please contact us at the following:

Contact Information:
email: press@heartseed.jp